OVERLAND PARK, Kan., Sept. 17, 2019 /PRNewswire/ -- Rx Savings Solutions has partnered with

ABBOTT PARK, Ill., Sept. 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP™ 15mm rotatable mechanical heart valve and the Amplatzer Piccolo™ Occluder have received CE Mark and are now available in Europe and other countries that recogniz

NEW YORK and BOSTON, Sept. 17, 2019 /PRNewswire/ -- Kaia Health, a digital therapeutics company, today announced an $8 million funding round, the second significant investment this year. The infusion of capital is led by Optum Ventures.

DENVER, Sept. 17, 2019 /PRNewswire/ -- Concept3D, a leader in creating immersive online experiences with 3D modeling, interactive maps and virtual tour software, today announced that the University of Colorado Anschutz Medical Campus launched a new VR-enabled virtual tour of its facilities using Concept3D's software. CU Anschutz us

CINCINNATI, Sept. 17, 2019 /PRNewswire/ -- The Central and Southern Ohio chapter of the Healthcare Information and Management Systems Society (CSO HIMSS) announced two September events; an inaugural Charity Golf Tournament and Annual Fall Conference, Clinical and Operational Data Driven Innovation. The Charity Golf Tournamen

WASHINGTON, Sept. 17, 2019 /PRNewswire/ -- Paralyzed Veterans of America today announced it will honor Democratic U.S. Senator Tammy Duckworth of

CHICAGO, Sept. 17, 2019 /PRNewswire/ -- Our nation is facing a youth e-cigarette epidemic. Last year alone, there was a 78% increase in high school kids vaping, and according to preliminary data from the National Youth Tobacco Survey, 27.5% of youth are now using e-cigarettes. This dramatic increase in vaping places youths' developing lungs at risk of irreversible l

WASHINGTON, Sept. 17, 2019 /PRNewswire/ -- Paralyzed Veterans of America Deputy Executive Director Shaun Castle issued the following statement regardi

NEW YORK, Sept. 17, 2019 /PRNewswire/ --  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced the treatment of the last patient in the primary cohort of the Phase IIb HbA1c trial evaluating Oramed's lead oral insulin candidate, ORMD-0801, which

LAKEWOOD, Ohio, Sept. 17, 2019 /PRNewswire/ -- Roundstone, a Lakewood-based health insurance provider specializing in self-funded group captive solutions, is proud to announce the launch of its newly redesigned website at